Statin Consumer Medication Guides Requested By HRG In Wake Of Baycol
Executive Summary
FDA should issue mandatory medication guides warning consumers about the risk of rhabdomyolysis and death with use of statin cholesterol-lowering drugs, the Public Citizen's Health Research Group said in an Aug. 20 petition.
You may also be interested in...
AERS Database Cannot Determine Adverse Event Incidence, FDA Says In Rejecting Statin Label Warning
FDA denies Public Citizen’s 2001 petition requesting a black box warning about the risk of rhabdomyolysis on cholesterol-lowering drug labels, says Baycol and high-dose simvastatin are outliers.
AstraZeneca Defends Crestor; Public Citizen Renews Call For Withdrawal
The post-marketing safety profile of Crestor is in line with the overall experience of the statin category, AstraZeneca said May 19 in response to a renewed request from Public Citizen for withdrawal of the cholesterol-lowering drug
AstraZeneca Defends Crestor; Public Citizen Renews Call For Withdrawal
The post-marketing safety profile of Crestor is in line with the overall experience of the statin category, AstraZeneca said May 19 in response to a renewed request from Public Citizen for withdrawal of the cholesterol-lowering drug